Nektar Therapeutics
NKTR
NKTR
243 hedge funds and large institutions have $2.92B invested in Nektar Therapeutics in 2020 Q4 according to their latest regulatory filings, with 37 funds opening new positions, 80 increasing their positions, 86 reducing their positions, and 38 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
243
Holders Change
-3
Holders Change %
-1.22%
% of All Funds
4.31%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
37
Increased
80
Reduced
86
Closed
38
Calls
$20.8M
Puts
$10.6M
Net Calls
+$10.2M
Net Calls Change
+$6.25M
Top Buyers
1 |
MC
Maverick Capital
Dallas,
Texas
|
+$16.6M |
2 |
First Trust Advisors
Wheaton,
Illinois
|
+$13.5M |
3 |
Millennium Management
New York
|
+$8.66M |
4 |
D.E. Shaw & Co
New York
|
+$7.59M |
5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$7.46M |